Other potentially clinically relevant genes with single base somatic mutations include NOTCH2, recently proposed as an oncogene in bladder cancer [45], with the Notch family pathway implicated in prostate tumorigenesis [46], and CNTN6 within the 3p26 prostate cancer susceptibility locus [47]. This evidence concerns the gene CNTN6 and Familial prostate cancer.